• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

已发表健康经济学肥胖模型的复制:促进因素、障碍和复制成功率的评估。

Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success.

机构信息

Department of Health Services Research, CAPHRI-Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

AHEAD GmbH-Agency for Health Economic Assessment and Dissemination, Waschhausgasse 17, 79540, Lörrach, Germany.

出版信息

Pharmacoeconomics. 2021 Apr;39(4):433-446. doi: 10.1007/s40273-021-01008-7. Epub 2021 Mar 10.

DOI:10.1007/s40273-021-01008-7
PMID:33751452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8009773/
Abstract

OBJECTIVES

This research aims to (1) replicate published health economic models, (2) compare reproduced results with original results, (3) identify facilitators and hurdles to model replicability and determine reproduction success, and (4) suggest model replication reporting standards to enhance model reproducibility, in the context of health economic obesity models.

METHODS

Four health economic obesity models simulating an adult UK population were identified, selected for replication, and evaluated using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Reproduction results were compared to original results, focusing on cost-effectiveness outcomes, and the resulting reproduction success was assessed by published criteria. Replication facilitators and hurdles were identified and transferred into related reporting standards.

RESULTS

All four case studies were state-transition models simulating costs and quality-adjusted life-years (QALYs). Comparing original versus reproduction outcomes, the following deviation ranges were observed: costs - 3.9 to 16.1% (mean over all model simulations 3.78%), QALYs - 3.7 to 2.1% (mean - 0.11%), and average cost-utility ratios - 3.0 to 17.9% (mean 4.28%). Applying different published criteria, an overall reproduction success was observed for three of four models. Key replication facilitators were input data tables and model diagrams, while missing standard deviations and missing formulas for equations were considered as key hurdles.

CONCLUSIONS

This study confirms the feasibility of rebuilding health economic obesity models, but minor to major assumptions were needed to fill reporting gaps. Model replications can help to assess the quality of health economic model documentation and can be used to validate current model reporting practices. Simple changes to actual CHEERS reporting criteria may solve identified replication hurdles.

摘要

目的

本研究旨在:(1) 复制已发表的健康经济模型,(2) 将复制结果与原始结果进行比较,(3) 确定模型可复制性的促进因素和障碍,并确定复制成功的标准,以及(4) 提出模型复制报告标准,以提高健康经济肥胖模型的可复制性。

方法

确定并选择了 4 个模拟英国成年人的健康经济肥胖模型进行复制,并使用健康经济评估报告标准一致性(CHEERS)清单进行评估。通过发表的标准评估复制成功的程度,重点关注成本效益结果,并比较原始结果和复制结果。确定复制的促进因素和障碍,并将其转化为相关的报告标准。

结果

所有四个案例研究都是模拟成本和质量调整生命年(QALYs)的状态转移模型。比较原始结果和复制结果,观察到以下偏差范围:成本 - 3.9% 至 16.1%(所有模型模拟的平均值为 3.78%),QALYs - 3.7% 至 2.1%(平均值为-0.11%),以及平均成本效益比 - 3.0% 至 17.9%(平均值为 4.28%)。根据不同的发表标准,四个模型中有三个模型的整体复制成功率很高。关键的复制促进因素是输入数据表和模型图,而缺失标准偏差和方程的公式被认为是关键障碍。

结论

本研究证实了重建健康经济肥胖模型的可行性,但需要对假设进行细微到重大的调整以填补报告中的空白。模型复制可以帮助评估健康经济模型文档的质量,并可用于验证当前的模型报告实践。对实际 CHEERS 报告标准进行简单的修改可能会解决已确定的复制障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f4/8009773/1a067300874b/40273_2021_1008_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f4/8009773/1a067300874b/40273_2021_1008_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4f4/8009773/1a067300874b/40273_2021_1008_Fig1_HTML.jpg

相似文献

1
Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success.已发表健康经济学肥胖模型的复制:促进因素、障碍和复制成功率的评估。
Pharmacoeconomics. 2021 Apr;39(4):433-446. doi: 10.1007/s40273-021-01008-7. Epub 2021 Mar 10.
2
Barriers and Facilitators to Model Replication Within Health Economics.健康经济学模型复制的障碍和促进因素。
Value Health. 2019 Sep;22(9):1018-1025. doi: 10.1016/j.jval.2019.04.1928. Epub 2019 Jul 16.
3
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.健康经济评估报告标准(CHEERS)——解释与说明:国际卫生经济学会健康经济评估报告指南良好报告实践工作组报告。
Value Health. 2013 Mar-Apr;16(2):231-50. doi: 10.1016/j.jval.2013.02.002.
4
Assessment of the quality and trend of reporting of health economic evaluation research in India.评估印度卫生经济评价研究报告的质量和趋势。
Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):595-599. doi: 10.1080/14737167.2021.1858055. Epub 2020 Dec 9.
5
A systematic review of the quality and scope of economic evaluations in child oral health research.儿童口腔健康研究中经济评估的质量和范围的系统评价。
BMC Oral Health. 2019 Jul 1;19(1):132. doi: 10.1186/s12903-019-0825-2.
6
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.《健康经济评估报告标准(CHEERS)》2022 年解释与详述:ISPOR CHEERS II 良好实践工作组报告。
Value Health. 2022 Jan;25(1):10-31. doi: 10.1016/j.jval.2021.10.008.
7
Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?当前用于描述成本效益模型中健康状态效用的报告标准是否令人满意?
Value Health. 2020 Mar;23(3):397-405. doi: 10.1016/j.jval.2019.12.004. Epub 2020 Feb 15.
8
Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs.生物治疗方案在改善中重度类风湿关节炎患者中的应用:一项疾病修饰抗风湿药物治疗失败后的经济学评价的系统综述
Pharmacoeconomics. 2020 May;38(5):459-471. doi: 10.1007/s40273-020-00887-6.
9
Cost-Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review.干预非正规照护者的成本-效用分析:系统和批判性评价。
Pharmacoeconomics. 2020 Apr;38(4):341-356. doi: 10.1007/s40273-019-00874-6.
10

引用本文的文献

1
Evaluation of Reporting Quality of Systematic Reviews on Health Economic Evaluation Studies Based on the CHEERS Statement: An Overview of Reviews.基于CHEERS声明对卫生经济评估研究系统评价报告质量的评估:综述概述
Iran J Public Health. 2024 Oct;53(10):2214-2225. doi: 10.18502/ijph.v53i10.16699.
2
Testicular fat deposition attenuates reproductive performance via decreased follicle-stimulating hormone level and sperm meiosis and testosterone synthesis in mouse.睾丸脂肪沉积通过降低小鼠卵泡刺激素水平、精子减数分裂和睾酮合成来削弱生殖性能。
Anim Biosci. 2024 Jan;37(1):50-60. doi: 10.5713/ab.23.0175. Epub 2023 Aug 28.
3

本文引用的文献

1
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge.评估糖尿病经济模型模拟新型心血管结局试验的能力:第九次胡德山糖尿病挑战赛报告。
Value Health. 2020 Sep;23(9):1163-1170. doi: 10.1016/j.jval.2020.04.1832. Epub 2020 Aug 6.
2
Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics.能再说一遍吗?探索健康经济学中成功模型复制的定义。
Pharmacoeconomics. 2019 Nov;37(11):1371-1381. doi: 10.1007/s40273-019-00836-y.
3
Barriers and Facilitators to Model Replication Within Health Economics.
Reproducibility and Scientific Integrity of Big Data Research in Urban Public Health and Digital Epidemiology: A Call to Action.
大数据研究在城市公共卫生和数字流行病学中的可重复性和科学诚信:行动呼吁。
Int J Environ Res Public Health. 2023 Jan 13;20(2):1473. doi: 10.3390/ijerph20021473.
4
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity.结构是否重要?严重肥胖症事件模拟方法的外部验证和健康经济学结果比较。
Pharmacoeconomics. 2022 Sep;40(9):901-915. doi: 10.1007/s40273-022-01162-6. Epub 2022 Jun 30.
健康经济学模型复制的障碍和促进因素。
Value Health. 2019 Sep;22(9):1018-1025. doi: 10.1016/j.jval.2019.04.1928. Epub 2019 Jul 16.
4
Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.开发美国医疗体系的开源模型:开源价值项目的实践经验和当前挑战。
Pharmacoeconomics. 2019 Nov;37(11):1313-1320. doi: 10.1007/s40273-019-00827-z.
5
Publication of Decision Model Source Code: Attitudes of Health Economics Authors.决策模型源代码的发布:卫生经济学作者的态度
Pharmacoeconomics. 2019 Nov;37(11):1409-1410. doi: 10.1007/s40273-019-00796-3.
6
Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018.2010 年至 2018 年,清单在健康经济评价综述中的应用。
Value Health. 2019 Mar;22(3):377-382. doi: 10.1016/j.jval.2018.10.006. Epub 2018 Dec 14.
7
Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.骨质疏松症经济评估实施建议:由欧洲临床与经济骨质疏松症、骨关节炎和肌肉骨骼疾病学会(ESCEO)和国际骨质疏松基金会美国分会组织的专家共识会议的结果。
Osteoporos Int. 2019 Jan;30(1):45-57. doi: 10.1007/s00198-018-4744-x. Epub 2018 Oct 31.
8
Event simulation and external validation applied in published health economic models for obesity: a systematic review.事件模拟与外部验证在已发表的肥胖症健康经济模型中的应用:一项系统评价。
Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):529-541. doi: 10.1080/14737167.2018.1501680. Epub 2018 Jul 24.
9
Replicating Health Economic Models: Firm Foundations or a House of Cards?复制健康经济模型:坚实基础还是纸牌屋?
Pharmacoeconomics. 2017 Nov;35(11):1113-1121. doi: 10.1007/s40273-017-0553-x.
10
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models.开源卫生经济模型的益处、挑战及潜在策略
Pharmacoeconomics. 2017 Jan;35(1):125-128. doi: 10.1007/s40273-016-0479-8.